Want to read a big number? $34 million is a pretty big number, isn't it? That's how much CytoPhrex has raised in venture capital, which pretty much sets the record for 2011. And 2010 for that matter.
Excerpt:
"Ann Arbor-based CytoPherx Inc., a clinical-stage medical device company initially focused on acute kidney failure, announced today that it has raised $34 million in venture capital, the largest round of such funding for a state company since Ann Arbor-based Lycera Corp. raised $36 million in April 2009."
Read the rest
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.